After the state legalized recreational marijuana in 2016, new taxes and regulations decimated an ad hoc network that had donated cannabis for medical purposes to patients who could not afford it. A recent law seeks to revive the network, but hurdles remain.
Category: Veterans’ Health
FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.